The experience of allergic rhinitis treatment in children with Levocetirizine

G.O. Lezhenko, O.E. Pashkova


The paper deals with the experience of using the antihistamine drug of the 3rd generation levocetirizine (L-Cet, Kusum Farm Ltd.) for the treatment of allergic rhinitis in children. The high effectiveness of the drug, good tolerability and facility are proved that allows re­commend it for the complex therapy of allergic rhinitis in children.


allergic rhinitis; children; levocetirizine


Brożek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, Schünemann HJ. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010 Sep;126(3):466-76. doi: 10.1016/j.jaci.2010.06.047.

Antypkin YuG, Lapshyn VF, Umanets TR, Kondratenkova TV. [Efficacy of L-cet use in children with seasonal allergic rhinitis. Zdorov’ye Rebenka. 2013;8(51):21-3. (In Ukrainian). doi: 10.22141/2224-0551.8.51.2013.84951.

Fang SY, Perng DW, Lee JY, Lin DY, Huangs CY. An open-label, multicentre study of levocetirizine for the treatment of allergic rhinitis and urticaria in Taiwanese patients. Chin J Physiol. 2010 Aug;53(4):199-207. doi: 10.4077/CJP.2010.AMK007.

Melamed I, Heffron M. Attention Deficit Disorder and Allergic Rhinitis: Are They Related? Journal of Immunology Research. 2016;2016:6. doi: 10.1155/2016/1596828.

Sidorovich OI, Luss LV. Modern approaches to the treatment of allergic rhinitis. Astma i allergija 2015;4:27-32. (In Russian).

Kurbacheva OM, Gushchin IS. Kestine in treatment of perennial rhinitis in adults and child. Rossijskij Allergologicheskij Zhurnal. 2004;4:75-8. (In Russian).

Davis S. Summer "sniffles": ear, nose and throat. SA Pharmacist's Assistant. 2015;15(4): 8-10.

Phan H, Moeller ML, Nahata MC. Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast. Drugs. 2009;69(18):2541-76. doi: 10.2165/9884960-000000000-00000.

Sur DK, Scandale S. Treatment of allergic rhinitis. Am Fam Physician. 2010;81:1440-6. PMID: 20540482.

Bialiayeva LM, Mikulchik NV, Panulina NI. Allergic rhinitis in children: current diagnostic, treatment and prophilactic. Mezhdunarodnye Obzory: Klinicheskaja Praktika i Zdorov'ye. 2013;2(221): 34-9. (In Russian).

Olasińska-Wiśniewska A, Olasiński J, Grajek S. Cardiovascular safety of antihistamines. Advances in Dermatology and Allergology. 2014;31(3):182-6. doi: 10.5114/pdia.2014.43191.

Carnovale C, Russo S, Biondelli G, Gentili M, Pozzi M, Antoniazzi S, Clementi E. Levocetirizine-induced psychiatric disorders in a pediatric patient: A case report and a pharmacovigilance database analysis. Journal of Pharmacology and Pharmacotherapeutics. 2017;8(2):74-6. doi: 10.4103/jpp.JPP_14_17.

Trusova OV, Korostovtsev DS. Levotsetirizin (Ksizal). Harakteristika preparata i opyit klinicheskogo primeneniya [Levocetirizine (Xyzal). The characteristics of the drug and clinical experience]. Allergologiya. 2006;2:25-31. (In Russian).

Gillard M, Christophe B, Wels B, Peck M, Massingham R, Chatelain P. H1 antagonists: receptor affinity versus selectivity. Inflammation Research. 2003;52:49-50. doi: 10.1007/s000110300050.

Astafieva NG, Gamova IV, Udovichenko EN, Perfilova IA. Levocetirizine: modern aspects of the use in allergic diseases in terms of evidence-based medicine. Lechaschiy vrach. 2010;5(5):62. (In Russian).

Kondyurina EG, Zelenskaya VV. The antihistamines in the control of allergic diseases in children. Rossiyskiy Meditsinskiy Zhurnal. 2012;2:56-8. (In Russian).

De Blic J, Wahn U, Billard E, Alt R, Pujazon MC. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatr Allergy Immunol. 2005;16(3):267-75. doi: 10.1111/j.1399-3038.2005.00216.x.

Potter PC; Paediatric Levocetirizine Study Group. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial. Ann Allergy Asthma Immunol. 2005;95(2):175-80. doi: 10.1016/S1081-1206(10)61208-2.

Dubuske LM. Levocetirizine: The latest treatment option for allergic rhinitis and chronic idiopathic urticaria. Allergy Asthma Proc. 2007;28(6):724-34. doi: 10.2500/aap.2007.28.3051.

Simons FE; Early Prevention of Asthma in Atopic Children Study Group. H1-antihistamine treatment in young atopic children: effect on urticaria. Ann Allergy Asthma Immunol. 2007;99(3):261-6. doi: 10.1016/S1081-1206(10)60662-X.

McDonald K, Trick L, Boyle J. Sedation and antihistamines: an update. Review of inter-drug differences using proportional impairment ratios. Hum. Psychopharmacol. 2008;23(7):555-70. doi: 10.1002/hup.962.

Snidvongs K, Seresirikachorn K, Khattiyawittayakun L, Chitsuthipakorn W. Sedative Effects of Levocetirizine: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. Drugs. 2017;77(2):175-86. doi: 10.1007/s40265-016-0682-0.

Ten Eick AP, Blumer JL, Reed MD. Safety of antihistamines in children. Drug safety. 2001;24(2):119-47. doi: 10.2165/00002018-200124020-00003.

Hulhoven R, Rosillon D, Letiexhe M, Meeus MA, Daoust A, Stockis A. Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study. European journal of clinical pharmacology. 2007;63(11):1011-7. doi: 10.1007/s00228-007-0366-5.

Pasquali M, Baiardini I, Rogkakou A, Riccio AM, Gamalero C, Descalzi D, Canonica GW. Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. Clinical & Experimental Allergy, 2006;36(9):1161-7. doi: 10.1111/j.1365-2222.2006.02548.x.

Van Bever HP, Samuel ST, Lee BW. Halting the allergic march. World Allergy Organization Journal. 2008;1(4):57-62. doi: 10.1097/WOX.0b013e31816ddbc1.

Bousquet PJ, Combescure C, Klossek JM, Daurès JP, Bousquet J. Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis. Journal of Allergy and Clinical Immunology. 2009;123(6):1349-54. doi: 10.1016/j.jaci.2009.02.033.



  • There are currently no refbacks.

Copyright (c) 2017 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2018


   Seo анализ сайта